Metadherin mediates Lipopolysaccharide-induced migration and invasion of breast cancer cells

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Zhao, Yuhan ^a   Kong, Xiaoli ^a   Li, Xiaoyan ^a   Yan, Shi ^b   Yuan, Cunzhong ^b   Hu, Wenwei ^c   Yang, Qifeng ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG UNIVERSITY   (China)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; SHORT HAIRPIN RNA; CELL ADHESION MOLECULE; CYTOKINE; MTDH PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 4;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL ASSAY; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INACTIVATION; GENETIC STABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; METADHERIN GENE; ONCOGENE; PROTEIN SYNTHESIS INHIBITION; TRANSCRIPTION INITIATION; UPREGULATION; BIOASSAY; BIOSYNTHESIS; BREAST TUMOR; CELL MOTION; DISEASE COURSE; DRUG EFFECT; FEMALE; GENE SILENCING; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE; TUMOR MICROENVIRONMENT;

BIOLOGICAL ASSAY; BREAST NEOPLASMS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MOVEMENT; CYTOKINES; DISEASE PROGRESSION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIPOPOLYSACCHARIDES; NEOPLASM INVASIVENESS; NF-KAPPA B; SIGNAL TRANSDUCTION; TIME FACTORS; TOLL-LIKE RECEPTOR 4; TUMOR MICROENVIRONMENT; UP-REGULATION;

EID: 83455221361     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029363     Document Type: Article

References (38)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Knudson AG, (2001) Two genetic hits (more or less) to cancer. Nat Rev Cancer 1: 157-162.
3. Emdad L, Lee SG, Su ZZ, Jeon HY, Boukerche H, et al. (2009) Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis. Proc Natl Acad Sci U S A 106: 21300-21305.
4. Hu G, Chong RA, Yang Q, Wei Y, Blanco MA, et al. (2009) MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 15: 9-20.
5. Sutherland HG, Lam YW, Briers S, Lamond AI, Bickmore WA, (2004) 3D3/lyric: a novel transmembrane protein of the endoplasmic reticulum and nuclear envelope, which is also present in the nucleolus. Exp Cell Res 294: 94-105.
6. Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky DJ, et al. (2005) Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 353: 8-15.
7. Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, et al. (2007) Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene 26: 7647-7655.
8. Chen W, Ke Z, Shi H, Yang S, Wang L, (2010) Overexpression of AEG-1 in renal cell carcinoma and its correlation with tumor nuclear grade and progression. Neoplasma 57: 522-529.
9. Song H, Li C, Li R, Geng J, (2010) Prognostic significance of AEG-1 expression in colorectal carcinoma. Int J Colorectal Dis 25: 1201-1209.
10. Emdad L, Sarkar D, Su ZZ, Lee SG, Kang DC, et al. (2007) Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol Ther 114: 155-170.
11. Khuda II, Koide N, Noman AS, Dagvadorj J, Tumurkhuu G, et al. (2009) Astrocyte elevated gene-1 (AEG-1) is induced by lipopolysaccharide as toll-like receptor 4 (TLR4) ligand and regulates TLR4 signalling. Immunology 128: e700-706.
12. Zhang B, Liu XX, He JR, Zhou CX, Guo M, et al. (2011) Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis 32: 2-9.
13. Hu G, Wei Y, Kang Y, (2009) The multifaceted role of MTDH/AEG-1 in cancer progression. Clin Cancer Res 15: 5615-5620.
14. Li J, Zhang N, Song LB, Liao WT, Jiang LL, et al. (2008) Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 14: 3319-3326.
15. Su P, Zhang Q, Yang Q, (2010) Immunohistochemical analysis of Metadherin in proliferative and cancerous breast tissue. Diagn Pathol 5: 38.
16. Brown DM, Ruoslahti E, (2004) Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 5: 365-374.
17. Li C, Li R, Song H, Wang D, Feng T, et al. (2011) Significance of AEG-1 expression in correlation with VEGF, microvessel density and clinicopathological characteristics in triple-negative breast cancer. J Surg Oncol 103: 184-192.
18. Liu X, Zhang N, Li X, Moran MS, Yuan C, et al. (2011) Identification of novel variants of metadherin in breast cancer. PLoS One 6: e17582.
19. Qian BJ, Yan F, Li N, Liu QL, Lin YH, et al. (2011) MTDH/AEG-1-based DNA vaccine suppresses lung metastasis and enhances chemosensitivity to doxorubicin in breast cancer. Cancer Immunol Immunother.
20. Balkwill F, Mantovani A, (2001) Inflammation and cancer: back to Virchow? Lancet 357: 539-545.
21. Coussens LM, Werb Z, (2002) Inflammation and cancer. Nature 420: 860-867.
22. Huang B, Zhao J, Unkeless JC, Feng ZH, Xiong H, (2008) TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 27: 218-224.
23. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, et al. (2004) NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431: 461-466.
24. Lee SG, Su ZZ, Emdad L, Sarkar D, Fisher PB, (2006) Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci U S A 103: 17390-17395.
25. Lu YC, Yeh WC, Ohashi PS, (2008) LPS/TLR4 signal transduction pathway. Cytokine 42: 145-151.
26. Inoue J, Gohda J, Akiyama T, Semba K, (2007) NF-kappaB activation in development and progression of cancer. Cancer Sci 98: 268-274.
27. Sarkar D, Park ES, Emdad L, Lee SG, Su ZZ, et al. (2008) Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res 68: 1478-1484.
28. Hanahan D, Weinberg Robert A, (2011) Hallmarks of Cancer: The Next Generation. Cell 144: 646-674.
29. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
30. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A, (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30: 1073-1081.
31. Mantovani A, Allavena P, Sica A, Balkwill F, (2008) Cancer-related inflammation. Nature 454: 436-444.
32. Pidgeon GP, Harmey JH, Kay E, Da Costa M, Redmond HP, et al. (1999) The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease. Br J Cancer 81: 1311-1317.
33. Gonzalez-Reyes S, Marin L, Gonzalez L, Gonzalez LO, del Casar JM, et al. (2010) Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis. BMC Cancer 10: 665.
34. Connelly L, Barham W, Onishko HM, Sherrill T, Chodosh LA, et al. (2011) Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden. Oncogene 30: 1402-1412.
35. Harmey JH, Bucana CD, Lu W, Byrne AM, McDonnell S, et al. (2002) Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. Int J Cancer 101: 415-422.
36. Waugh DJJ, Wilson C, (2008) The Interleukin-8 Pathway in Cancer. Clinical Cancer Research 14: 6735-6741.
37. Brunn GJ, Bungum MK, Johnson GB, Platt JL, (2005) Conditional signaling by Toll-like receptor 4. FASEB J 19: 872-874.
38. Rahim S, Beauchamp EM, Kong Y, Brown ML, Toretsky JA, et al. (2011) YK-4-279 Inhibits ERG and ETV1 Mediated Prostate Cancer Cell Invasion. PLoS One 6: e19343.